14-75963344-G-A

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong

The NM_003239.5(TGFB3):​c.898C>T​(p.Arg300Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R300Q) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

TGFB3
NM_003239.5 missense

Scores

14
4
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 2.54
Variant links:
Genes affected
TGFB3 (HGNC:11769): (transforming growth factor beta 3) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. This protein is involved in embryogenesis and cell differentiation, and may play a role in wound healing. Mutations in this gene are a cause of aortic aneurysms and dissections, as well as familial arrhythmogenic right ventricular dysplasia 1. [provided by RefSeq, Aug 2016]
IFT43 (HGNC:29669): (intraflagellar transport 43) This gene encodes a subunit of the intraflagellar transport complex A (IFT-A). IFT-A is a multiprotein complex that plays an important role in cilia assembly and maintenance by mediating retrograde ciliary transport. Mutations in this gene are a cause of cranioectodermal dysplasia-3 (CED3), also known as Sensenbrenner syndrome. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr14-75963343-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 143945.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.843
PP5
Variant 14-75963344-G-A is Pathogenic according to our data. Variant chr14-75963344-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 203490.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-75963344-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TGFB3NM_003239.5 linkuse as main transcriptc.898C>T p.Arg300Trp missense_variant 5/7 ENST00000238682.8
TGFB3NM_001329939.2 linkuse as main transcriptc.898C>T p.Arg300Trp missense_variant 6/8
TGFB3NM_001329938.2 linkuse as main transcriptc.898C>T p.Arg300Trp missense_variant 5/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TGFB3ENST00000238682.8 linkuse as main transcriptc.898C>T p.Arg300Trp missense_variant 5/71 NM_003239.5 P1P10600-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461852
Hom.:
0
Cov.:
33
AF XY:
0.00000275
AC XY:
2
AN XY:
727218
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 10, 2016- -
Likely pathogenic, criteria provided, single submitterclinical testingBlueprint GeneticsJul 13, 2018- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxApr 27, 2022Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25835445, 31898322, 27848944, 29392890) -
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsNov 13, 2018The p.R300W pathogenic mutation (also known as c.898C>T), located in coding exon 5 of the TGFB3 gene, results from a C to T substitution at nucleotide position 898. The arginine at codon 300 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration is located in the latency-associated peptide domain and has been reported in individuals and families with hypertelorism, bifid uvula and/or cleft palate, and other overlapping Loeys-Dietz and Marfan syndrome-like features (Bertoli-Avella AM et al. J. Am. Coll. Cardiol., 2015 Apr;65:1324-36; Trujillano D et al. Eur. J. Hum. Genet., 2017 02;25:176-182; Schepers D et al. Hum. Mutat., 2018 May;39:621-634). Other substitutions at this amino acid position, p.R300Q and p.R300G, have been identified in families with similar clinical findings, as well as in an affected individual reported as a de novo case (Matyas G et al. Am. J. Med. Genet. A, 2014 Aug;164A:2141-3; Kuechler A et al. Mol. Cell. Probes, 2015 Oct;29:330-4). Internal structural analysis indicates that alterations at this position disrupt the putative furin pro-peptide cleavage motif of the protein (Dubois CM et al. J. Biol. Chem., 1995 May;270:10618-24; Lafyatis R. Nat Rev Rheumatol, 2014 Dec;10:706-19; Ambry internal data). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Likely pathogenic, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioDec 04, 2018- -
Rienhoff syndrome Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 17, 2023This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 300 of the TGFB3 protein (p.Arg300Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Loeys-Dietz syndrome (PMID: 25835445, 31898322). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 203490). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on TGFB3 protein function. This variant disrupts the p.Arg300 amino acid residue in TGFB3. Other variant(s) that disrupt this residue have been observed in individuals with TGFB3-related conditions (PMID: 24798638, 26184463), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
Pathogenic, no assertion criteria providedliterature onlyOMIMApr 07, 2015- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.36
D
BayesDel_noAF
Pathogenic
0.28
CADD
Pathogenic
26
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.96
D;.
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D;D
M_CAP
Pathogenic
0.32
D
MetaRNN
Pathogenic
0.84
D;D
MetaSVM
Uncertain
0.52
D
MutationAssessor
Uncertain
2.4
M;M
MutationTaster
Benign
1.0
D;D
PrimateAI
Pathogenic
0.85
D
PROVEAN
Pathogenic
-6.6
D;D
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0010
D;D
Polyphen
1.0
D;.
Vest4
0.83
MutPred
0.66
Loss of disorder (P = 0.0104);Loss of disorder (P = 0.0104);
MVP
0.89
MPC
1.6
ClinPred
0.98
D
GERP RS
4.5
Varity_R
0.75
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs796051885; hg19: chr14-76429687; COSMIC: COSV53170944; COSMIC: COSV53170944; API